T1	Haplotype	51 105	CYP2D6 alleles * 4 , * 5 , * 10 , * 41 -all associated
T2	Pharmacodynamic_phenotype	111 161	impaired formation of antiestrogenic metabolites -
T3	Phenotype	184 205	recurrences of breast
T4	Disease	184 222	recurrences of breast cancer , shorter
T5	Phenotype	223 252	relapse-free periods ( hazard
T6	Phenotype	333 364	survival rates ( HR , 1.89 ; 95
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	increases	Arg1:T1	Arg2:T3
R3	increases	Arg1:T1	Arg2:T4
R4	decreases	Arg1:T1	Arg2:T5
R5	decreases	Arg1:T1	Arg2:T6
R6	increases	Arg1:T2	Arg2:T3
R7	increases	Arg1:T2	Arg2:T4
R8	decreases	Arg1:T2	Arg2:T5
R9	decreases	Arg1:T2	Arg2:T6
R10	isAssociatedWith	Arg1:T3	Arg2:T2
R11	decreases	Arg1:T3	Arg2:T5
R12	decreases	Arg1:T3	Arg2:T6
R13	isAssociatedWith	Arg1:T4	Arg2:T2
R14	decreases	Arg1:T4	Arg2:T5
R15	decreases	Arg1:T4	Arg2:T6
R16	isAssociatedWith	Arg1:T5	Arg2:T1
R17	isAssociatedWith	Arg1:T5	Arg2:T2
R18	isAssociatedWith	Arg1:T5	Arg2:T3
R19	isAssociatedWith	Arg1:T5	Arg2:T4
R20	decreases	Arg1:T5	Arg2:T6
R21	isAssociatedWith	Arg1:T6	Arg2:T1
R22	isAssociatedWith	Arg1:T6	Arg2:T2
R23	isAssociatedWith	Arg1:T6	Arg2:T3
R24	isAssociatedWith	Arg1:T6	Arg2:T4
R25	decreases	Arg1:T6	Arg2:T5
